# A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV

> **NCT06919016** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 45 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** DV700P-RNA
- **BIOLOGICAL:** DV701B1.1-RNA

## Key facts

- **NCT ID:** NCT06919016
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2027-03-25
- **Final completion:** 2027-03-25
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919016, "A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06919016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*